搜索临床试验以:huCART19
总计27个结果
-
University of Pennsylvania完全的
-
University of PennsylvaniaChildren's Hospital of Philadelphia主动,不招人
-
University of Pennsylvania主动,不招人
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company主动,不招人
-
Stephan Grupp MD PhDUniversity of Pennsylvania招聘中
-
Stephan Grupp MD PhDChildren's Hospital of Philadelphia招聘中B 细胞急性淋巴细胞白血病 (B-ALL) | B系淋巴母细胞淋巴瘤美国
-
Shenzhen Second People's Hospital未知
-
University of PennsylvaniaTheriva Biologics SL招聘中
-
Stephan Grupp MD PhDUniversity of Pennsylvania招聘中患有亚二倍体或 t(17;19) B-ALL 的儿科和年轻成人患者 | KMT2A B-ALL 风险极高的婴儿 | 未接受颅内放疗或骨髓移植的中枢神经系统复发患者美国
-
University of PennsylvaniaNational Institutes of Health (NIH); Tmunity Therapeutics, a wholly owned subsidiary of Kite...主动,不招人
-
Fundamenta Therapeutics, Ltd.Anhui Provincial Hospital招聘中
-
National Institute of Allergy and Infectious Diseases...University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF)尚未招聘
-
Fundamenta Therapeutics, Ltd.The Affiliated Hospital of Xuzhou Medical University招聘中
-
University of Pennsylvania撤销急性淋巴细胞白血病 | 慢性淋巴细胞白血病 | 非霍奇金淋巴瘤
-
Sara V. LatorreInstituto de Salud Carlos III; Institut d'Investigacions Biomèdiques August Pi i Sunyer主动,不招人
-
University of PennsylvaniaChildren's Hospital of Philadelphia终止
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm Oncology完全的急性淋巴细胞白血病 | 非霍奇金淋巴瘤 | 最小残留病 | 小淋巴细胞淋巴瘤 | 急性双表型白血病 | III期慢性淋巴细胞白血病 | IV 期慢性淋巴细胞白血病 | CD19阳性 | 破坏 5% 或更多的骨髓有核细胞美国
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.招聘中弥漫性大 B 细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 3b 级滤泡性淋巴瘤 | 转化滤泡淋巴以鉴别大 B 细胞淋巴瘤 | 转化 Marg 区淋巴以鉴别大 B 细胞淋巴瘤美国